WebApr 6, 2024 · Biophytis Publishes its Financial Results for the First Half of 2024. Cash and cash equivalents: €19.7m as of June 30, 2024 Net loss down 8% at €12.4m for first half of 2024 Publication of restated financial results as of December 31st, 2024 PARIS, FRANCE / CAMBRIDGE, M... 2 months ago - Accesswire. WebJan 12, 2024 · Biophytis Contact for Investor Relations. Philippe Rousseau CFO. [email protected]. Media Contacts. Antoine Denry:[email protected] +33 6 18 07 83 27 Agathe Boggio:agathe.boggio@taddeo ...
Biophytis
WebStock BIOPHYTIS Common Stock FR0012816825 ALXP Euronext Growth Paris Live Euronext cours de bourse, cotation temps réel, graphiques et communiqués réglementés … WebLe cours de l'action BIOPHYTIS ALBPS en temps réel sur Boursorama : historique de la cotation sur Euronext Paris, graphique, actualités, consensus des analystes et … Retrouvez l'espace actionnaires pour BIOPHYTIS ALBPS Euronext Paris sur … can i travel after taking abortion pill
Biophytis To Present Positive Results of Phase 2-3 COVA Study At …
WebSep 17, 2024 · Biophytis leadership team reinforced with new senior appointments Cash on hand increased to €23 million as of June 30 th 2024, compared to €18.8 million as of December 31 2024, following ... WebApr 7, 2024 · Biophytis SA announces its non audited financial results for the year ended December 31, 2024, and provides updates on key operational achievements as well as perspectives for 2024. ... (USA)in December 2024, in March 2024 Biophytis received approval from the Belgian FAMHP to proceed with its clinical investigation of Sarconeos … WebApr 7, 2024 · SEC Filings. Filing Date. Form. Description. March 27, 2024. 6-K. On March 27, 2024, Biophytis S.A. issued a press release announcing the presentation of Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Research (ICFSR). … can i travel around the world